SEC Form 4 · accession 0001209191-18-045510
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Aug 2, 2018
Accepted (ET)
Aug 6, 2018 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 2, 2018 | M | 21,500 | $5.5004 | A | 56,995 | D | |
| Common StockF2 | Aug 2, 2018 | S | 7,965 | $150.3137 | D | 49,030 | D | |
| Common StockF3 | Aug 2, 2018 | S | 3,976 | $151.5876 | D | 45,054 | D | |
| Common StockF4 | Aug 2, 2018 | S | 2,601 | $152.5134 | D | 42,453 | D | |
| Common StockF5 | Aug 2, 2018 | S | 3,358 | $153.3472 | D | 39,095 | D | |
| Common StockF6 | Aug 2, 2018 | S | 3,100 | $154.579 | D | 35,995 | D | |
| Common StockF7 | Aug 2, 2018 | S | 500 | $155.42 | D | 35,495 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $5.5004 | Aug 2, 2018 | M | 21,500 | D | — | Jan 16, 2023 | Common Stock | 21,500 | 5,507 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range of prices for the transaction reported on this line was $150.00 to $150.95. The average weighted price was $150.3137. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $151.00 to $151.95. The average weighted price was $151.5876. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $152.00 to $152.95. The average weighted price was $152.5134. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $153.00 to $153.95. The average weighted price was $153.3472. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $154.00 to $154.95. The average weighted price was $154.5790. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $155.35 to $155.55. The average weighted price was $155.42. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013 and as of May 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014 and May 1, 2014, respectively, with the remainder of the shares vesting in equal monthly installments over the following three years.